BIOLARGO, INC. BLGO
BIOLARGO, INC. (BLGO) earns a Piotroski F-score of 0/9 (weak financial health). It does not currently pay a dividend.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 2036 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 0/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| BLGO | BIOLARGO, INC. | 0/9 | — | — | -56.3% |
| LQMT | LIQUIDMETAL TECHNOLOGIES INC | 2/9 | -15.56 | — | — |
| LOOP | Loop Industries, Inc. | 1/9 | — | — | -95.3% |
| GURE | GULF RESOURCES, INC. | 3/9 | — | — | — |
| ACNT | ASCENT INDUSTRIES CO. | 6/9 | 8.71 | 144.9 | -7.2% |
| BCPC | BALCHEM CORP | 8/9 | 6.82 | 35.5 | +8.8% |
| NGVT | Ingevity Corp | 6/9 | 2.97 | — | -2.7% |
About BIOLARGO, INC.
BioLargo, Inc. invents, develops, and commercializes various platform technologies in the United States. The company's technologies solve challenging environmental problems comprising per- and polyfluoroalkyl substances (PFAS) water contamination; advanced water and wastewater treatment; industrial odor and volatile organic compounds control, air quality control, and infection control; and myriad environmental remediation. It provides full-service environmental engineering, battery energy storage, and advanced antimicrobial medical device platforms. BioLargo, Inc. is based in Westminster, California.
FAQ
Is BLGO financially healthy?
BIOLARGO, INC.'s Piotroski F-score is 0/9 (8–9 is excellent, 0–3 weak).
Does BLGO pay a dividend?
No, BIOLARGO, INC. does not currently pay a dividend.
What is the analyst price target for BLGO?
The average Wall-Street price target for BIOLARGO, INC. is $0.32, about 255.6% above the recent price, from 1 analysts.
Is BLGO a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on BIOLARGO, INC.: a Piotroski F-score of 0/9. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.